FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994328771> ?p ?o ?g. }

• W2994328771 abstract "Abstract Background Determination of β-amyloid (Aβ) positivity and likelihood of underlying Alzheimer’s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and Aβ within the normal range may still have a substantial risk of developing dementia, primarily of Alzheimer type. Their prognosis, as well as predictors of clinical progression, are not fully understood. The aim of this study was to explore the associations of cerebrospinal fluid (CSF) biomarkers (Aβ42, total tau, phosphorylated tau) and other characteristics, including modifiable vascular factors, with the risk of progression to dementia among patients with MCI and normal CSF Aβ42. Methods Three hundred eighteen memory clinic patients with CSF and clinical data, and at least 1-year follow-up, were included. Patients had normal CSF Aβ42 levels based on clinical cut-offs. Cox proportional hazard models with age as time scale and adjusted for sex, education, and cognition (Mini-Mental State Examination) were used to investigate predictors of progression to dementia and Alzheimer-type dementia. Potential predictors included CSF biomarkers, cognitive performance (verbal learning and memory), apolipoprotein E ( APOE ) ε4 genotype, medial temporal lobe atrophy, family history of dementia, depressive symptoms, and vascular factors, including the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) risk score. Predictive performance of patient characteristics was further explored with Harrell C statistic. Results Lower normal Aβ42 and higher total tau and phosphorylated tau were associated with higher dementia risk, and the association was not driven by Aβ42 values close to cut-off. Additional predictors included poorer cognition, APOE ε4 genotype, higher systolic blood pressure, and lower body mass index, but not the CAIDE dementia risk score. Aβ42 individually and in combination with other CSF biomarkers improved the risk prediction compared to age and cognition alone. Medial temporal lobe atrophy or vascular factors did not increase the predictive performance. Conclusions Possibility of underlying AD pathology and increased dementia risk should not be ruled out among MCI patients with CSF Aβ42 within the normal range. While cut-offs may be useful in clinical practice to identify high-risk individuals, personalized risk prediction tools incorporating continuous biomarkers may be preferable among individuals with intermediate risk. The role of modifiable vascular factors could be explored in this context." @default.
• W2994328771 created "2019-12-13" @default.
• W2994328771 creator A5026262571 @default.
• W2994328771 creator A5033559171 @default.
• W2994328771 creator A5038918680 @default.
• W2994328771 creator A5039518658 @default.
• W2994328771 creator A5067566922 @default.
• W2994328771 creator A5086456642 @default.
• W2994328771 date "2019-12-01" @default.
• W2994328771 modified "2023-10-17" @default.
• W2994328771 title "Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid" @default.
• W2994328771 cites W1559001474 @default.
• W2994328771 cites W1587329234 @default.
• W2994328771 cites W1667362502 @default.
• W2994328771 cites W1847168837 @default.
• W2994328771 cites W1949174883 @default.
• W2994328771 cites W1963487177 @default.
• W2994328771 cites W1970283678 @default.
• W2994328771 cites W1974583546 @default.
• W2994328771 cites W1981636437 @default.
• W2994328771 cites W1991517279 @default.
• W2994328771 cites W2008854521 @default.
• W2994328771 cites W2043715766 @default.
• W2994328771 cites W2052226124 @default.
• W2994328771 cites W2055649795 @default.
• W2994328771 cites W2058161128 @default.
• W2994328771 cites W2061391028 @default.
• W2994328771 cites W2064126078 @default.
• W2994328771 cites W2065338300 @default.
• W2994328771 cites W2078251961 @default.
• W2994328771 cites W2082997471 @default.
• W2994328771 cites W2098706789 @default.
• W2994328771 cites W2106931873 @default.
• W2994328771 cites W2112150247 @default.
• W2994328771 cites W2115017507 @default.
• W2994328771 cites W2116709840 @default.
• W2994328771 cites W2122847075 @default.
• W2994328771 cites W2124670646 @default.
• W2994328771 cites W2129497119 @default.
• W2994328771 cites W2144907160 @default.
• W2994328771 cites W2147776113 @default.
• W2994328771 cites W2147883225 @default.
• W2994328771 cites W2148080316 @default.
• W2994328771 cites W2148573574 @default.
• W2994328771 cites W2152163581 @default.
• W2994328771 cites W2156220037 @default.
• W2994328771 cites W2157110881 @default.
• W2994328771 cites W2158894504 @default.
• W2994328771 cites W2166609052 @default.
• W2994328771 cites W2167311298 @default.
• W2994328771 cites W2167840686 @default.
• W2994328771 cites W2168283959 @default.
• W2994328771 cites W2168412413 @default.
• W2994328771 cites W2171524950 @default.
• W2994328771 cites W2291435159 @default.
• W2994328771 cites W2299205157 @default.
• W2994328771 cites W2551920754 @default.
• W2994328771 cites W2582524520 @default.
• W2994328771 cites W2587777515 @default.
• W2994328771 cites W2588515696 @default.
• W2994328771 cites W2589963787 @default.
• W2994328771 cites W2598117906 @default.
• W2994328771 cites W2603308917 @default.
• W2994328771 cites W2605015761 @default.
• W2994328771 cites W2619945698 @default.
• W2994328771 cites W2735952353 @default.
• W2994328771 cites W2766003287 @default.
• W2994328771 cites W2767297946 @default.
• W2994328771 cites W2774314613 @default.
• W2994328771 cites W2792163733 @default.
• W2994328771 cites W2798054687 @default.
• W2994328771 cites W2888171838 @default.
• W2994328771 cites W2897070036 @default.
• W2994328771 cites W2902271881 @default.
• W2994328771 cites W2943828894 @default.
• W2994328771 cites W2972912589 @default.
• W2994328771 cites W2973037195 @default.
• W2994328771 doi "https://doi.org/10.1186/s13195-019-0557-1" @default.
• W2994328771 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6896336" @default.
• W2994328771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31805990" @default.
• W2994328771 hasPublicationYear "2019" @default.
• W2994328771 type Work @default.
• W2994328771 sameAs 2994328771 @default.
• W2994328771 citedByCount "19" @default.
• W2994328771 countsByYear W29943287712020 @default.
• W2994328771 countsByYear W29943287712021 @default.
• W2994328771 countsByYear W29943287712022 @default.
• W2994328771 countsByYear W29943287712023 @default.
• W2994328771 crossrefType "journal-article" @default.
• W2994328771 hasAuthorship W2994328771A5026262571 @default.
• W2994328771 hasAuthorship W2994328771A5033559171 @default.
• W2994328771 hasAuthorship W2994328771A5038918680 @default.
• W2994328771 hasAuthorship W2994328771A5039518658 @default.
• W2994328771 hasAuthorship W2994328771A5067566922 @default.
• W2994328771 hasAuthorship W2994328771A5086456642 @default.
• W2994328771 hasBestOaLocation W29943287711 @default.
• W2994328771 hasConcept C118552586 @default.
• W2994328771 hasConcept C126322002 @default.
• W2994328771 hasConcept C143998085 @default.
• W2994328771 hasConcept C15744967 @default.

• next